The Ohio-based health system said it had reason to believe ransomware group Interlock launched the attack in late May. Kettering is still recovering from the incident, which disrupted patient care.
Ransomware group linked to cyberattack on Kettering Health Read More »
The companies scrapped the merger because securing FTC clearance “proved unviable in terms of time, expense and opportunity.”
Owens & Minor spikes $1.36B Rotech buyout over regulatory barriers Read More »
The American Public Health Association and dozens of other experts had harsh words for Georgia’s request to continue its controversial “Pathways to Coverage,” saying it enrolls fewer beneficiaries at a higher cost.
Public health scholars ask HHS to reject Georgia Medicaid work requirement extension Read More »
The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and speedy speech.
Perspective Therapeutics Brings Energy to the Radiopharma World Read More »
If the tube moves out of place, it could prevent a patient from breathing or block the airway. A Medtronic spokesperson said patient harm was reported in some cases.
Medtronic removes tracheostomy tubes due to dislodging risk Read More »
Otsuka’s investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with immunoglobulin A nephropathy.
Otsuka Sees ‘Impressive’ Proteinuria Reduction in Phase III IgAN Trial Read More »
Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include the “very rare” risk of non-arteritic anterior ischemic optic neuropathy.
EU Regulators Confirm Rare Vision Loss Risk for Novo’s Semaglutide Read More »
En un mundo donde movernos de forma eficiente y responsable es cada vez más importante, guppy se presenta como una solución práctica, flexible y respetuosa con el entorno. Esta plataforma de movilidad sostenible ofrece una amplia flota de vehículos 100 % el&eacu …
guppy: la alternativa de movilidad sostenible para tus trayectos diarios Read More »
Analysts at Truist Securities called the mid-stage data a “mixed bag,” also flagging gastrointestinal adverse events. However, the readout is unlikely to be “incremental” to Corcept’s overall stock narrative.
Corcept Claims Survival Benefit in ALS Despite Missed Endpoint Read More »
In a roundtable event on Thursday, HHS Secretary Robert F. Kennedy Jr. said his office will work to eliminate barriers that keep cell and gene therapies from the market.
